Insiders · Profile

Sandler Alan B.

Chief Development Officer at Revolution Medicines. Filing since 16 Sep 2026. CIK 0001835966

Company
Date
Role
Action
Shares
Amount
Of holding
29 Sep 2026
Chief Development Officer
Sold on a plan
6,309
$1.28M
10.7%
16 Sep 2026
Chief Development Officer
Sold on a plan
341
$67.94K
0.6%
2 decisions on file.